Seroprevalence and risk factors of human herpes virus 8 infection in Central-East Tunisia;Séroprévalence et facteurs de risque de l'infection par le virus herpès humain 8 dans le Centre-Est tunisien

Pathologie Biologie

Volumn 60, Issue 5, 2012, Pages 282-286

  Hannachi, N ^a   Ben Fredj, N ^a,b   Samoud, S ^a   Ferjani, A ^a   Khlif, A ^a   Boughammoura, L ^a   Soussi, S ^a   Aouni, M ^b   Skouri, H ^c   Boukadida, J ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

HHV8; Risk factor; Seroprevalence; Tunisia

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; DEMOGRAPHY; HEPATITIS B; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN HERPES VIRUS 8 INFECTION; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; INFECTION RATE; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION RESEARCH; PREGNANT WOMAN; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL ASPECT; TUNISIA;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; TUNISIA; YOUNG ADULT;

EID: 84867562957     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.10.008     Document Type: Article

References (36)

1. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
2. Marcelin A.G., Duplin N., Calvez V. Herpès virus humain 8. Traité de virologie médicale 2003, 237-245. ESTEM, Paris. J.M. Hureaux, J.C. Nicolas, H. Agut, H. Peigue-Lafeuille (Eds.).
3. Kedes D.H., Operskalski E., Busch M., Kohn R., Flood J., Ganem D. The seroepidemiology of human herpes virus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996, 2:918-924.
4. Plancoulaine S., Abel L., Gessain A. épidémiologie du virus herpès humain 8 (HHV-8) ou virus herpès associé au sarcome de Kaposi (KSHV). Pathol Biol 2002, 50:496-502.
5. Bourboulia D., Whitby D., Boshoff C., Newton R., Beral V., Carrara H., et al. Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. JAMA 1998, 280(1):31-32.
6. Calabrò M.L., Gasperini P., Fiore J.R., Barbierato M., Angarano G., Chieco-Bianchi L. Intrafamilial transmission of human herpesvirus 8. J Natl Cancer Inst 2001, 93(2):154-156.
7. Hladik W., Dollard S.C., Mermin J., Fowlkes A.L., Downing R., Amin M.M., et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006, 355(13):1331-1338.
8. Cannon M.J., Operskalski E.A., Mosley J.W., Radford K., Dollard S.C. Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort. J Infect Dis 2009, 199(11):1592-1598.
9. Dukers N.H., Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS 2003, 17(12):1717-1730.
10. Martin J.N., Ganem E.D., Osmond D.H., Page-Shaffer K.A., Macrae D.N., Kedes D.H. Sexual transmission and the natural history of human herpesvirus 8 infection. AIDS 1998, 338(14):948-954.
11. Serraino D., Toma L., Andreoni M., Butto S., Tchangmena O., Sarmati L., et al. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol 2001, 17:871-876.
12. Cattani P., Cerimele F., Porta D., Graffeo R., Ranno S., Marchetti S., et al. Age-specific seroprevalence of Human Herpesvirus 8 in Mediterranean regions. Clin Microbiol Infect 2003, 9:274-279.
13. Ben Tekaya N., Zeglaoui F., Ben Abdallah T., Ben Chaabane T., Fazaa B., Mokhtar I., et al. Kaposi's sarcoma in Tunisia. Review of 91 cases. Tunis Med 2001, 79:429-433.
14. Angeloni A., Masala M.V., Montesu M.A., Santarelli R., Satta R., Ceccherini-Nelli L., et al. Environmental factors influence the rate of Human Herpesvirus type 8 infection in a population with high incidence of classic Kaposi sarcoma. Clin Infect Dis 2006, 42:66-68.
15. Lennette E.T., Blackbourn D.J., Levy J.A. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348(9031):858-861.
16. Suchánková A., Stanková M., Roubalová K., Vandasová J., Brůcková M. Seroprevalence of HHV 8 antibodies among the general population and HIV positive persons in the Czech Republic. J Clin Virol 2003, 28(1):70-76.
17. Souza V.A., Sumita L.M., Freire W., Sato H.K., Grandi J.L., Pierrotti L.C., et al. Prevalence of antibodies to human herpesvirus-8 in populations with and without risk for infection in São Paulo State. Braz J Med Biol Res 2004, 37(1):123-127.
18. Ablashi D., Chatlynne L., Cooper H., Thomas D., Yadav M., Norhanom A.W., et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 1999, 81(5):893-897.
19. Mayama S., Cuevas L.E., Sheldon J., Omar O.H., Smith D.H., Okong P., et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998, 77:817-820.
20. Andreoni M., El-Sawaf G., Rezza G., Ensoli B., Nicastri E., Ventura L., et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst 1999, 91:465-469.
21. Gessain A., Mauclere P., Van Beveren M., Plancoulaine S., Ayouba A., Essame-Oyono J.L., et al. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999, 81:189-192.
22. Vieira J., Huang M., Koelle D.M., Corey L. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 1997, 71:7083-7087.
23. Taylor M.M., Chohan B., Lavreys L., Hassan W., Huang M.L., Corey L., et al. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and seronegative Kenyan women. J Infect Dis 2004, 190:484-488.
24. Gargouri J., Elleuch H., Karray H., Rekik H., Hammami A. Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Tunis Med 2000, 78:512-517.
25. Hannachi N., Marzouk M., Harrabi I., Ferjani A., Ksouri Z., Ghannem H., et al. Séroépidémiologie de la rubéole, de la varicelle et des infections par le cytomégalovirus et le parvovirus B19 chez les femmes enceintes dans la région de Sousse, Tunisie. Bull Soc Pathol Exot 2011, 104(1):62-67.
26. Hengge U.R., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002, 2(5):281-292.
27. Huang L.M., Huang S.Y., Chen M.Y., Chao M.F., Lu C.Y., Tien H.F., et al. Geographical differences in human herpesvirus 8 seroepidemiology: a survey of 1,201 individuals in Asia. J Med Virol 2000, 60:290-293.
28. Challine D., Roudot-Thoraval F., Sarah T., Laperche L., Boisson B., Mauberquez S., et al. Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 2001, 41:1120-1125.
29. Perna A.M., Bonura F., Vitale F., Viviano E., Di Benedetto M.A., Ajello F., et al. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 2000, 29:175-179.
30. Rezza G., Lennette E.T., Giuliani M., Pezzotti P., Caprilli F., Monini P., et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 1998, 77:361-365.
31. Cottoni F., Santarelli R., Gentile G., Gallisai D., Capobianchi A., Masala M.V., et al. High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy. J Clin Virol 2004, 30:106-109.
32. Parravicini C., Olsen S.J., Capra M., Poli F., Sirchia G., Gao S.J., et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma patients. Blood 1997, 90(7):2826-2829.
33. Regamey N., Tamm M., Wernli M., Witschi A., Thiel G., Cathomas G., et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998, 339(19):1358-1363.
34. Harzallah K., Abderrahim E., Chareffedine K., Yeich S., Belhadj R., Skhiri H., et al. Kidney Dis Transpl 2008, 19:825-830.
35. Michaels M.G., Jenkins F.J. Human herpesvirus 8: is it time for routine surveillance in pediatric solid organ transplant recipients to prevent the development of Kaposi's sarcoma?. Pediatr Transplant 2003, 7:1-3.
36. Triki H., Said N., Ben Salah A., Arrouji A., Ben Ahmed F., Bouguerra A., et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997, 91(1):11-14.